Pediatric Infection and Vaccine
- 제7권2호
- /
- Pages.240-244
- /
- 2000
- /
- 2384-1079(pISSN)
- /
- 2384-1087(eISSN)
Rifampin으로 폐결핵 치료 중 발생한 혈소판 감소증 1례
A Case of Rifampin-induced Thrombocytopenia in Pulmonary Tuberculosis
-
박석원
(연세대학교 원주의과대학 소아과학교실)
;
- 조희숙 (연세대학교 원주의과대학 소아과학교실) ;
- 김황민 (연세대학교 원주의과대학 소아과학교실) ;
- 임백근 (연세대학교 원주의과대학 소아과학교실) ;
- 김종수 (연세대학교 원주의과대학 소아과학교실)
-
Park, Seok Won
(Department of Pediatrics, Wonju College of Medicine, Yonsei University)
;
- Cho, Hee Suk (Department of Pediatrics, Wonju College of Medicine, Yonsei University) ;
- Kim, Hwang Min (Department of Pediatrics, Wonju College of Medicine, Yonsei University) ;
- Lim, Baek Keun (Department of Pediatrics, Wonju College of Medicine, Yonsei University) ;
- Kim, Jong Soo (Department of Pediatrics, Wonju College of Medicine, Yonsei University)
- 발행 : 2000.11.30
초록
저자들은 흉막삼출액을 동반한 폐결핵으로 입원한 13세 여아가 isoniazid 및 rifampin으로 치료 중 혈소판 감소증을 보였으며, 혈소판이 정상으로 회복된 후 리팜핀의 재투여로 발생한 혈소판 감소증 1례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.
Rifampin is a bactericidal antibiotic used primarily in the treatment of tuberculosis. The adverse effects of rifampin, though few, include dermatologic, gastrointestinal, and hepatic manifestations. Occasionally it produces a flu-like syndrome, interstitial nephritis, hemolytic anemia, and thrombocytopenia. These manifestations usually appear in patients who take the drug intermittently. We experienced a 13 year-old girl who developed thrombocytopenia during rifampin administration of daily dosage, therefore we report a brief review with the related literatures.